April 2011 – March 2013 n(%) | All IPC MRSA data | IPC-ProvLab matched data | p value* | ||
---|---|---|---|---|---|
n = 4818 | n = 2211 | ||||
Clinical n = 1569 (32.7) | Screening n = 3249 (67.4) | Clinical n = 1393 (63.0) | Screening n = 818 (37.0) | < 0.05 | |
Gender | 0.25 | ||||
Male | 825 (52.6) | 1699 (52.3) | 724 (52.0) | 446 (54.5) | |
Age (Years) | < 0.05 | ||||
Mean Age (±SD) | 57 (25.4) | 66 (22.8) | 56 (25.1) | 63 (22.6) | |
Median Age (IQR) | 61 (18.1) | 73 (11.4) | 59 (18.2) | 67 (14.9) | |
Case Classification | |||||
Hospital Acquired | 645 (41.1) | 1077 (33.1) | 578 (41.5) | 192 (23.5) | < 0.01** |
Healthcare | 326 (20.8) | 978 (30.1) | 277 (19.9) | 276 (33.7) | < 0.04** |
Associated | |||||
Community Acquired | 598 (38.1) | 1194 (36.7) | 538 (38.6) | 350 (42.8) | < 0.01** |
Facility Bed Size | |||||
>500 | 681 (43.4) | 1847 (56.8) | 621 (44.6) | 460 (56.2) | 0.75 |
251–500 | 285 (18.2) | 495 (15.2) | 245 (17.6) | 144 (17.6) | 0.1 |
100–250 | 233 (14.9) | 334 (10.3) | 210 (15.1) | 87 (10.6) | 0.76 |
<100 | 370 (23.6) | 573 (17.6) | 317 (22.8) | 127 (15.5) | 0.15 |
Severity | |||||
Infected | 1432 (91.3) | n/a | 1274 (91.5) | n/a | 0.86 |
Clinical Culture Site | |||||
Blood | 142 (9.1) | n/a | 130 (9.3) | n/a | 0.79 |
Other Sterile | 89 (5.7) | 88 (6.3) | 0.45 | ||
Skin/Soft Tissue | 947 (60.4) | 830 (59.6) | 0.67 | ||
Infected Device | 35 (2.2) | 29 (2.1) | 0.78 | ||
Respiratory | 193 (12.3) | 172 (12.3) | 0.97 | ||
Urine | 163 (10.4) | 144 (10.3) | 0.96 |